Benzyl Bromide → 5-(Benzyloxy)-2-bromopyridine

HRID 404151

반응식

HRID 404151 반응식
[Br:1][C:2]1[CH:7]=[CH:6][C:5]([OH:8])=[CH:4][N:3]=1.[H-].[Na+].[CH2:11](Br)[C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1.CCOC(C)=O>CN(C=O)C>[CH2:11]([O:8][C:5]1[CH:6]=[CH:7][C:2]([Br:1])=[N:3][CH:4]=1)[C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1

참가 물질

6

실험 절차

2-Bromo-5-hydroxypyridine (347 mg, 2 mmol) in DMF (3 mL) was added dropwise over a period of 10 min to a suspension of NaH (88 mg, 2.3 mmol) in DMF (2 mL) at 0° C. under Ar(g). The reaction mixture was then stirred at rt for 10 min, after which it was again cooled down at 0° C., and benzyl bromide (0.25 mL, 2.1 mmol) was added. The reaction mixture was stirred at rt for 2.5 h, after which it was poured onto brine (20 mL) and EtOAc (20 mL) was added. The phases were separated and the aqueous phase was extracted with EtOAc (20 mL). The organic phases were combined, dried over MgSO4, filtered and subsequently evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography eluting with hexane/EtOAc (95:5 to 90:10) to furnish I as a colourless oil (380 mg, 72%).

후처리

  1. temperatureafter which it was again cooled down at 0° C.
  2. stirringThe reaction mixture was stirred at rt for 2.5 h
  3. additionwas added
  4. customThe phases were separated
  5. extractionthe aqueous phase was extracted with EtOAc (20 mL)
  6. dry with materialdried over MgSO4
  7. filtrationfiltered
  8. customsubsequently evaporated under reduced pressure
  9. customThe resulting residue was purified by silica gel column chromatography
  10. washeluting with hexane/EtOAc (95:5 to 90:10)

출처 및 근거

ORD 기록
ord-a5c72394a02a403c9619268dfe3b6390
출처 데이터셋
uspto-grants-2014_06
특허 번호
US08748458B2

연결된 노트

불러오는 중…